Dapagliflozin improves radial and longitudinal strain, increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of doxorubicin cardiotoxicity through NLRP3 and Myd-88
Nicola Maurea(Cancer Institute (WIA)), Vincenzo Quagliariello(Cancer Institute (WIA)), Antonio Luciano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuseppe Palma(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Rosalaura Sabetta(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Carlo Maurea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Renato Franco(Istituto di Chimica Biomolecolare), Isabella Bisceglia(Azienda Ospedaliera San Camillo-Forlanini), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesca Bruzzese(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Marco Montella(University of Campania "Luigi Vanvitelli"), Michelangela Barbieri(University of Campania "Luigi Vanvitelli"), Maria Laura Canale(Ospedale Versilia), Francesco Paolo Zito(Ospedale Antonio Cardarelli)
Cited by 1
Related Papers
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108